90%Confidence
0Views
FDASource
2026-04-19Date
Summary
Additional sterility failures for K.C. Pharmaceuticals' lubricating eye drops impact major retailers including Cardinal Health and Harris Teeter. This expands the scope of quality control issues, increasing liability exposure for all distribution partners.
Actionable: Review all products sourced from K.C. Pharmaceuticals for potential quality control issues.
AI Confidence: 90%
Data Points
firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productUltra Lubricating Eye Drops (polyethylene 400 0.4%, propylene glycol 0.3%), Sterile, 0.5 FL OZ (15mL) bottles; a) LEADER, DISTRIBUTED BY CARDINAL HEAL
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now